OCT 12, 2015 07:10 PM PDT

Metabolic Engineering in Ten Easy Steps

WRITTEN BY: Kerry Evans
1 20 2632
Bacteria have the capacity to produce numerous substances for commercial and industrial applications. Despite this, very few strains are being used on an industrial scale, likely because such “metabolic engineering” requires a hefty investment.  Investigators at the Korea Advanced Institute of Science and Technology (KAIST) estimate that it requires anywhere from 50 to 300 person-years of work (!) and several hundred million dollars to engineer strains and implement their use on a large scale.  To stream-line the process, KAIST researchers Sang Yup Lee and Hyun Uk Kim recently published ten strategies to develop industrial microbial strains.
 
Korean scientists publish ten step "toolkit" for metabolic engineering.


Metabolic engineering seeks to optimize existing pathways in a cell to more efficiently produce a desired metabolite.  Often, this requires some degree of genetic engineering.  Strains of E. coli are already used to produce amino acids such as L-valine, L-lysine, L-arginine, and L-threonine, chemicals such as butanol, and succinic acid, as well as the anti-parasitic drug artemisinin.  Microbes can also be used to produce biofuels such as short-chain and fatty alcohols to replace gasoline and diesel.  

Lee and Kim’s ten strategies guide researchers from choosing the appropriate host strain, to implementing its use on a commercial scale.  They stress first and foremost the need to choose the most economically viable strain, giving special consideration to how easily particular strains can be genetically engineered.  When it comes to reconstructing or optimizing metabolic pathways, they recommend the use of “chemo-bioinformatic” tools to construct the most efficient pathways.  They also recommend removing any feedback inhibition controls that could diminish the amount of metabolite produced.  Another important consideration is how well the bacteria will tolerate the overproduction of certain metabolites, so called “product tolerance”.  It may be possible to greatly increase the amount of product made, but this may also inhibit the bacteria’s growth.  A final step in the development process is to ensure that engineered strains can be grown on a commercial scale, since oxygen and other nutrients can become limiting factors in large-scale cultures.            

According to Lee, “At the moment, the chance of commercializing microbial strains developed in academic labs is very low...We hope that these strategies contribute to improving opportunities to commercializing microbial strains developed in academic labs with drastically reduced costs and efforts, and that a large fraction of petroleum-based processes will be replaced with sustainable bioprocesses”.

Sources: Eurekalert, Nature Biotechnology, Wikipedia
 
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
MAY 17, 2018
Microbiology
MAY 17, 2018
Increased Concern as Ebola Outbreak Spreads to a City
Along with partners like Médecins Sans Frontières, WHO is springing into action to try to stop the spread of the virus.
MAY 29, 2018
Cancer
MAY 29, 2018
Early Research Makes Connection Between Liver Tumor Growth Control and Gut Microbiota
Our gut microbiota is unique, but many organisms are shared across populations of people. Early research shows a connection between liver tumors and the control of their growth by microbiota
JUN 04, 2018
Microbiology
JUN 04, 2018
Neutralizing Infections with Nanotechnology
Clearing bacterial infections from the body can present challenges. Engineers are trying to use nanorobots for such situations.
JUN 08, 2018
Clinical & Molecular DX
JUN 08, 2018
Early Detection of Tooth Decay from Bacterial Invasion
We all get cavities, but have we ever thought much about the biology of the process? From the Akson Russian Science Communication Association, scientists i
JUN 17, 2018
Microbiology
JUN 17, 2018
Humans & Mammals Have Very Different Skin Microbiomes
People share many genes with other organisms, but our skin microbiome diverges.
JUL 03, 2018
Microbiology
JUL 03, 2018
Undiagnosed Zika Infections may be Causing Miscarriage and Stillbirth
Zika virus might still be impacting pregnancies.
Loading Comments...